European Pharmaceutical Review

JULY 5, 2023

43: Identification and Classification of Nonconformities in Moulded and Tubular Glass Containers for Pharmaceutical Manufacturing. According the PDA, the standardised quality criteria in TR 43 are intended as a guidance overview for container manufacturers and for incoming container acceptance inspection at pharmaceutical companies.

Pharmaceutical Manufacturing 74

Pharmaceutical Manufacturing Packaging Documentation Pharmaceutical Companies 74

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings.

Pharmaceutical Manufacturing 45

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 45

European Pharmaceutical Review

JULY 18, 2023

Adoption of QMS within pharma and biopharma is increasing due to strict regulations, frequent changes in the manufacturing process and higher demand to increase production capacity. Some pharmaceutical companies are increasing their R&D spending to increase product numbers.

Documentation 94

Documentation Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 94

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 141% rise in company filings mentions of corporate governance in Q1 2023 compared with the previous quarter, with the highest share accounted for by GSK with 306% year-on-year increase, according to GlobalData’s analysis of over 898 pharmaceutical company filings.

Pharmaceutical Manufacturing 40

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 114% rise in company filings mentions of environmental sustainability in Q1 2023 compared with the previous quarter, with the highest share accounted for by Novozymes with 27% year-on-year increase, according to GlobalData’s analysis of over 757 pharmaceutical company filings.

Pharmaceutical Manufacturing 40

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 40

Pharmaceutical Technology

MAY 23, 2023

With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. Notably, the number of environmental sustainability-related patent applications in the pharmaceutical industry was 1,948 in Q1 2023, versus 2,528 in the prior quarter.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

European Pharmaceutical Review

OCTOBER 12, 2023

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.

Pharmaceutical Manufacturing 85

Pharmaceutical Manufacturing Vaccines Dosage Pharmaceutical Companies 85

PharmaState Academy

NOVEMBER 16, 2023

” The first panel at the Now & Next Summit featured prominent figures from top pharmaceutical companies. Additionally, digital technologies are crucial in quality management, supply chain, and product integrity within pharmaceutical manufacturing.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Communication 52

European Pharmaceutical Review

OCTOBER 17, 2022

Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceutical manufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.

Pharmaceutical Manufacturing 85

Pharmaceutical Manufacturing Packaging Diabetes Pharmaceutical Companies 85

European Pharmaceutical Review

AUGUST 31, 2023

[pharmaceutical companies] must take measures to manage antibiotic waste across the manufacturing supply chain” 2023 has so far, delivered a spectrum of change for antibiotic manufacturers across the pharmaceutical industry, from supply chain issues through to regulatory opportunities.

Pharmaceutical Companies 76

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing Hospitals 76

European Pharmaceutical Review

JUNE 6, 2023

Standard for antibiotic manufacturing to help combat AMR … Following this “ground-breaking standard” stated Courtney Soulsby, BSI Global Director for Healthcare Sustainability, the certification will “promote responsible pharmaceutical manufacturing and help protect the natural environment and slow antimicrobial resistance”.

Pharmaceutical Manufacturing 94

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 94

FDA Law Blog: Biosimilars

MARCH 6, 2024

His practice supports clients throughout the life sciences from biotech startups and multinational pharmaceutical companies to CROs and academic researchers to patient advocacy organizations.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Drug Development Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR). Other reasons include lower sales demand and high investment costs.

Drug Pricing 69

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 69

Pharmaceutical Technology

NOVEMBER 21, 2022

However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR). Other reasons include lower sales demand and high investment costs.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

European Pharmaceutical Review

APRIL 18, 2024

What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE).

Pharmaceutical Manufacturing 77

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 77

pharmaphorum

DECEMBER 28, 2022

So, how do smaller pharmaceutical companies at the cutting edge get ready for their acquisition milestone, so they maximise their value and attractiveness? Any purchasing company would ideally like to integrate their acquisitions into their company seamlessly.

Pharmaceutical Manufacturing 116

Pharmaceutical Manufacturing Documentation Pharmaceutical Companies Pharmaceutical Companies 116

European Pharmaceutical Review

JULY 12, 2022

Microbes developing resistance to disinfectants is a major emerging problem in pharmaceutical manufacturing cleanrooms and, if left unchecked, could present a threat to drug quality and, therefore, human health.

Pharmaceutical Manufacturing 97

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 97

Pharmaceutical Technology

SEPTEMBER 5, 2022

Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Wholesale distributors are responsible for guaranteeing product quality and preventing the influx of counterfeited drugs.

Documentation 52

Documentation Packaging Labelling Pharmaceutical Manufacturing 52

Pharmaceutical Technology

SEPTEMBER 20, 2022

Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. Identifying the top commercial dose (non-sterile) companies in contract marketing.

Documentation 52

Documentation Pharmaceutical Manufacturing Packaging Pharmaceutical Companies 52

European Pharmaceutical Review

SEPTEMBER 29, 2022

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

Nursing Homes 77

Nursing Homes Pharmaceutical Manufacturing Department of Veterans Affairs Dosage 77

Express Pharma

MARCH 15, 2024

He mentions that OPPI member companies follow the stringent OPPI Code of Pharmaceutical Practices 2019 (OPPI Code) which is based on the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) Code.

Pharmaceutical Manufacturing 91

Pharmaceutical Manufacturing Communication Pharmaceutical Companies Pharmaceutical Companies 91

Pharmaceutical Technology

SEPTEMBER 15, 2022

The pharmaceutical industry requires specialised and cost-effective commercial packaging solutions to improve efficiency and preserve the integrity of products through the entire supply chain, from primary packaging and labelling to shipping, delivery, storage and distribution to end users.

Packaging 52

Packaging Labelling Pharmaceutical Manufacturing Documentation 52

Express Pharma

APRIL 20, 2023

COVID-19 has sped up the digital transformation and forced pharmaceutical companies to rethink many aspects of their business. Continuous manufacturing The topic of continuous manufacturing is also discussed in frames of PHARMAP 2023. This leads to growth in the pharma industry by finding new solutions and innovations.

Packaging 52

Packaging Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 52

Viseven

JANUARY 13, 2023

So what do exactly HEOR experts do for the pharmaceutical companies and what HEOR-collected data is used for? HEOR collects all reports about health outcomes from patients and physicians and later provides detailed analytics to healthcare providers, clinical outcomes research institutions or pharmaceutical companies.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Drug Pricing 40

European Pharmaceutical Review

NOVEMBER 8, 2022

3) policing anticompetitive settlements between competing drug manufacturers. European pharmaceutical companies targeting the US market should be aware of these pending bills and their potential impacts on market entry, intellectual property enforcement and payer access. 5) monitoring access to biosimilars.

Biosimilars 52

Biosimilars Drug Pricing Pharmaceutical Manufacturing Pharmaceutical Companies 52

pharmaphorum

MARCH 22, 2022

the streamlining of pharma manufacturing in the 21st century. It is not just about bringing new technologies to pharmaceutical manufacturing, it’s also about making completely new ‘advanced therapies’ ready for production,” he outlined. “VR is an important element of Education 4.0, which is critical to Pharma 4.0,

Pharmaceutical Manufacturing 136

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 136

GMPSOP

FEBRUARY 28, 2024

This article will explore the key considerations, best practices, and regulatory requirements for effective cleaning and sanitation that pharmaceutical companies must adhere to for optimal cleanliness and safety. Sometimes, pharmaceutical manufacturers employ surface profilometry to assess the roughness of stainless-steel equipment.

Documentation 98

Documentation Packaging Pharmaceutical Manufacturing Compounding 98

pharmaphorum

DECEMBER 16, 2022

Compounding the situation to understand how such an outcome was allowed to occur is the fact that many deals between government and pharmaceutical companies selling the treatments and vaccines were agreed under terms of confidentiality. The discussions over the treaty are set to continue for some time.

Vaccines 91

Vaccines Pharmaceutical Manufacturing Compounding Labelling 91

European Pharmaceutical Review

OCTOBER 20, 2022

Annex 1 states that “at least one representative sample is included every day that the water is used for manufacturing processes” Another important aspect of grab sampling is the frequency, which is up to the pharmaceutical company to determine. Inspection Technical Guide – Water for Pharmaceutical Use.

Pharmaceutical Companies 89

Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 89

Quality Matters

SEPTEMBER 15, 2023

PCM not ideal for every drug Continuous manufacturing “may not be fit for every pharmaceutical manufacturing process, but it can bring some advantages in some cases” compared with traditional batch manufacturing, summarized FDA’s Adam Fisher, Ph.D.,

Pharmaceutical Manufacturing 52

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Dosage 52

European Pharmaceutical Review

AUGUST 17, 2022

We are the largest life sciences coalition bringing together various life science industry representatives,” including over 100 biotech, diagnostics, generics and research-based pharmaceutical companies and associations, to drive collaborative approaches and measure the life-sciences’ industry progress to curb AMR. 2019;15(3):312-319.

Hospitals 87

Hospitals Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 87

pharmaphorum

OCTOBER 27, 2022

The Guidance applies to all member companies of EFPIA and IFPMA, but also acts as useful guidance for all pharmaceutical companies as to how the authorities will interpret the legislative provisions to social media channels. The Guidance applies to both product-related and therapeutic-area-related activities.

Communication 96

Communication Pharmaceutical Manufacturing Packaging Documentation 96

pharmaphorum

AUGUST 25, 2020

Anyone in the UK who has any concerns about the activities of any pharmaceutical company can raise them with the PMCPA and be confident that it will be investigated under the auspices of a memorandum of understanding with the MHRA, backed up by UK law. That has contributed to improving the perception of the industry and of HCPs.

Pharmaceutical Manufacturing 83

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies 83

pharmaphorum

APRIL 15, 2021

Stef is a standing member of the European Federation of Pharmaceutical Industries Association’s Innovation Board Sponsored Committee, as well as a member of the International Federation of Pharmaceutical Manufacturers & Associations Regulatory Strategy Committee. About Astellas. Astellas Pharma Inc.

Labelling 62

Labelling Communication Pharmaceutical Manufacturing Pharmaceutical Companies 62

pharmaphorum

MARCH 22, 2021

The International Finance Corporation, the division of the World Bank Group that invests in the private sectors of emerging markets, has provided financing for several emerging market pharmaceutical manufacturers with the goal of boosting developing countries’ access to affordably priced drugs. About the author. Dr Subir K.

Vaccines 120

Vaccines Pharmaceutical Manufacturing Dosage Pharmaceutical Companies 120

GMPSOP

MARCH 20, 2024

SOP for instrument calibration: Instrument calibration is important for pharmaceutical manufacturing standards. Subscribe Prev PREVIOUS POST Kazi Hasan Kazi is a seasoned pharmaceutical industry professional with over 20 years of experience specializing in production operations, quality management, and process validation.

Documentation 52

Documentation Pharmaceutical Manufacturing Labelling Communication 52

Viseven

SEPTEMBER 14, 2023

Unexpected geographic factors Many pharmaceutical companies relying on global markets for drug materials are particularly vulnerable to shifting geopolitical situations. For instance, depending on sources in tariff-affected countries can substantially increase a pharma company’s operational expenses.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Pharmacy Procurement 52